Biodexa Pharmaceuticals PLC announced the activation of its first clinical study site for the Phase 3 Serenta trial, which aims to evaluate the efficacy and safety of eRapa in treating familial ...
Identification of High-Performing Safety Net Hospitals for Radical Cystectomy: Implications for National Cancer Institute Cancer Center Partnership Familial adenomatous polyposis (FAP) is an autosomal ...
Familial adenomatous polyposis (FAP) arises from inherited mutations in the APC tumour suppressor gene and is characterised by the development of hundreds to thousands of adenomatous polyps throughout ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results